Fetuin-A levels in obesity: Differences in relation to metabolic syndrome and correlation with clinical and laboratory variables

Archives of Medical Science

Volumn 8, Issue 5, 2012, Pages 826-833

  Ismail, Nagwa Abdallah ^a   Ragab, Shadia ^a   Abd El Dayem, Soha M ^a   Abd ElBaky, Abeer ^a   Salah, Nehal ^a   Hamed, Mona ^a   Assal, Heba ^a   Koura, Hala ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Fetuin A; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FETUIN A; HIGH DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84869774386     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.31616     Document Type: Article

References (30)

1. Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B. Biochem J 2003; 376: 135-45.
2. Briana DD, Boutsikou M, Gourgiotis D, et al. Alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med 2008; 21: 826-30.
3. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor auto phosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 164: 87-98.
4. Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F. A syno nymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 2005; 54: 2477-81.
5. Dahlman I, Eriksson P, Kaaman M, et al. Alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 2004; 47: 1974-9.
6. Chan D.C, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004; 4: 227-46.
7. Egyptian growth curves. Diabetes Endocrine Metabolism Pediatric Unit Cairo University Childern's Hospital 2009. Available at: http://dempuegypt. blogspot.com Accessed on 10 October 2011.
8. Pergher RNQ, de Melo ME, Halpern A, Mancini MC, Infantil LO. Is a diagnosis of metabolic syndrome applicable to children? J Pediatr (Rio J) 2010; 86: 101-8.
9. Tsukumo DM, Carvalho-Filho MA, Carvalheira JBC, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-98.
10. Stefan N, Hennige A, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-a is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853-7.
11. Stȩpień M, Wlazeł RN, Paradowski M, et al. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study. Arch Med Sci 2012; 8: 431-6.
12. Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002; 51: 2450-8.
13. Lin X, Braymer HD, Bray GA, York DA. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of dietinduced obesity. Life Sci 1998; 63: 145-53.
14. Reinehr T, Christian LR. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. Clin Endocrinol Metab 2008; 93: 4479-85.
15. Mori K, Emoto M, Yokoyama H, et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006; 29: 468.
16. Axelsson J, Wang X, Ketteler M, et al. Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease? Am J Nephrol 2008; 28: 669-76.
17. Lorant DP, Grujicic M, Hoebaus C, et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011; 34: 156-61.
18. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley M. Association between human and the metabolic syndrome. Circulation 2006; 113: 1760-7.
19. l'Allemand D, Wiegand S, Reinehr T, et al. APV-Study Group Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring) 2008; 16: 1672-9.
20. Kalabay L, Chavin K, Lebreton JP, Robinson KA, Buse MG, Arnaud P. Human recombinant 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm Metab Res 1998; 30: 1-6.
21. Xu Y, Xu M, Bi Y, et al. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis 2011; 216: 180-6.
22. Reinehr T, de Sousa G, Toschke M, Andler W. Long-term follow-up of cardiovascular disease risk factors in obese children after intervention. Am J Clin Nutr 2006; 84: 490-6.
23. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 164: 87-98.
24. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-405.
25. Xiang J, Li XY, Xu M, et al. Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese. J Clin Endocrinol Metab 2008; 93: 4107-12.
26. Vionnet N, Hani EH, Dupont S, et al. Genome wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67: 1470-80.
27. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Fetuin-A and kidney function in persons with coronary artery disease: data from the Heart and Soul Study. Nephrol Dial Transplant 2006; 21: 2144-251.
28. Hennige AM, Staiger H, Wicke C, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008; 3: 1.
29. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-92.
30. Stepien M, Rosniak-Bak K, Paradowski M et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit 2011; 17: PR13-8.